A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2010 |
| Reihe/Periodikum: | Annals of Oncology ; volume 21, issue 2, page 415-418 ; ISSN 0923-7534 |
| Verlag/Hrsg.: |
Elsevier BV
|
| Schlagwörter: | Oncology / Hematology |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26636377 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1093/annonc/mdp330 |
